CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
6,839,379
Share change
+468,201
Total reported value
$71,813,000
Price per share
$10.50
Number of holders
32
Value change
+$4,908,012
Number of buys
15
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q3 2018

As of 30 Sep 2018, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,839,379 shares. The largest 10 holders included ACUTA CAPITAL PARTNERS, LLC, WELLINGTON MANAGEMENT GROUP LLP, ARS Investment Partners, LLC, Cortina Asset Management, LLC, Vanguard Group Inc, ROYCE & ASSOCIATES LP, INGALLS & SNYDER LLC, GAGNON SECURITIES LLC, Gagnon Advisors, LLC, and WELLS FARGO & COMPANY/MN. This page lists 32 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.